+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Macrophage Stimulating Protein Receptor"

Macrophage Stimulating Protein Receptor - Pipeline Review, H2 2019 - Product Thumbnail Image

Macrophage Stimulating Protein Receptor - Pipeline Review, H2 2019

  • Drug Pipelines
  • August 2019
  • 62 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Macrophage Stimulating Protein Receptor (MSPR) is a type of enzyme that plays a role in the immune system. It is a receptor that binds to macrophage stimulating protein (MSP) and is involved in the regulation of macrophage activation and proliferation. MSPR is also involved in the regulation of inflammation and tissue repair. It is expressed in various tissues, including the lungs, liver, and spleen. The MSPR market is driven by the increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune diseases. The growing demand for targeted therapies and the increasing focus on personalized medicine are also driving the market. Additionally, the development of novel drugs and therapies for the treatment of these diseases is expected to further fuel the growth of the MSPR market. Some of the key players in the MSPR market include AbbVie, Inc., AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Merck & Co., Inc., Novartis AG, Pfizer, Inc., and Sanofi. Show Less Read more